Moreover, the analysis of the relationship between hub gene with the relapse‐free survival of HNSCC patients showed that only FGFR2 notably affected the survival time of HNSCC patients (Supplementary Figure S2). This evidence concerns the gene FGFR2 and head and neck squamous cell carcinoma.